Abstract P6-08-03: Dynamics of cancer stem cell surface marker, CD44 and CD44v6 in the antitumor efficacy of PARP inhibitor in combination with PI3K pathway inhibitor in TNBC xenograft model

Xiaoti Lin, Brian Leyland‐Jones, JH Carlson et al.|Cancer Research|2017

Cited by 0